Ming-Qing Zhu

Dr. Ming-Qing Zhu


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2018 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
LDLan Dai
Lan Dai
LHLinyan He
Linyan He
ZWZhaoyue Wang
Zhaoyue Wang
XBXia Bai
Xia Bai
YHYang He
Yang He
CRChanggeng Ruan
Changgeng Ruan
The present study aimed to illuminate the role of circulating T follicular helper (TFH) cells in patients diagnosed with chronic immune thrombocytopenia (cITP). Fifty‑four patients with cITP and 30 age‑matched healthy control subjects were enrolled in the present study. TFH cell frequencies, expression of CD4+ TFH cell‑associated cytokines, including interleukin (IL)‑2, IL‑4, IL‑10 and IL‑21 and associated regulatory mRNA expression levels including Bcl‑6, c‑Maf, Blimp‑1 and PD‑1 pre‑ and post‑treatment with intravenous immunoglobulin and corticosteroids, were detected by flow cytometry, ELISA and reverse transcription‑quantitative polymerase chain reaction, respectively. TFH cell frequencies of patients were significantly higher compared with healthy controls pre‑treatment (P<0.05). Following treatment, significantly decreased percentages of TFH cells were present in cITP responders (P<0.05). Correlation analysis revealed that the number of TFH cells was negatively correlated with the platelet count in the peripheral blood. Furthermore, analysis of inflammatory cytokines indicated significant differences in serum interleukin (IL)‑21 and IL‑10 between pretreated patients and healthy controls (P<0.05). Additionally, transcription factor B‑cell lymphoma (Bcl)‑6, c‑Maf and programmed death‑ligand (PD)‑1 mRNA expression levels were significantly different between cITP patients prior to treatment and the healthy controls (P<0.05). However, the expression levels of Bcl‑6, C‑Maf and PD‑1 mRNA were significantly changed post‑treatment (P<0.05). These data demonstrated that circulating TFH cells and CD4+ TFH cell‑associated cytokines may serve a role in cITP. The findings suggest that the overactivation of TFH cells may contribute to the immunopathogenesis of cITP, thus blocking the pathway of TFH cells may be reasonable for therapeutic intervention.

19 March 2024 in Discover Oncology
Verified
Journal Article
Open access
PDF file
MZMo Zhou
Mo Zhou
YCYan Chen
Yan Chen
YGYanlei Gong
Yanlei Gong
MZMing-Qing Zhu
Ming-Qing Zhu
JCJiannong Cen
Jiannong Cen
LYLi Yao
Li Yao
Purpose: To evaluate the efficacy of next-generation sequencing (NGS) in minimal-residual-disease (MRD) monitoring in Chinese patients with multiple myeloma (MM). Methods: This study analyzed 60 Chinese MM patients. During MRD monitoring in these patients’ post-therapy, clonal immunoglobulin heavy chain (IGH) rearrangements were detected via NGS using LymphoTrack assays. MRD monitoring was performed using NGS or next-generation flow cytometry (NGF), and the results were compared. Additionally, the sensitivity and reproducibility of the NGS method were assessed. Results: The MRD detection range of the NGS method was 10–6–10–1, which suggested good linearity, with a Pearson correlation coefficient of 0.985 and a limit of detection of 10–6. Intra- and inter-assay reproducibility analyses showed that NGS exhibited 100% reproducibility with low variability in clonal cells. At diagnosis, unique clones were found in 42 patients (70.0%) with clonal IGH rearrangements, which were used as clonality markers for MRD monitoring post-therapy. Comparison of NGS and NGF for MRD monitoring showed 79.1% concordance. No samples that tested MRD-positive via NGF were found negative via NGS, indicating the higher sensitivity of NGS. MRD could be detected using NGS in 6 of 7 samples before autologous hematopoietic stem-cell transplantation, and 5 of them tested negative post-transplantation. In contrast, the NGF method could detect MRD in only 1 sample pre-transplantation. Conclusion: Compared with NGF, NGS exhibits higher sensitivity and reproducibility in MRD detection and can be an effective strategy for MRD monitoring in Chinese MM patients.

1 July 2002
Verified
Journal Article
Closed access
YSYimin Shen
Yimin Shen
JLJianyong Li
Jianyong Li
YXYongquan Xue
Yongquan Xue
MZMing-Qing Zhu
Ming-Qing Zhu
DLDingwei Lu
Dingwei Lu
CRChanggeng Ruan
Changgeng Ruan

1 August 2016
Verified
Journal Article
Closed access
TWTong Wang
Tong Wang
RZRi Zhang
Ri Zhang
XQXiaofei Qi
Xiaofei Qi
SBSha-Sha Bai
Sha-Sha Bai
FGFang Gong
Fang Gong
LDLan Dai
Lan Dai

1 October 2002
Verified
Journal Article
Closed access
XTXiaowen Tang
Xiaowen Tang
DWDepei Wu
Depei Wu
YXYongquan Xue
Yongquan Xue
MZMing-Qing Zhu
Ming-Qing Zhu
DLDingwei Lu
Dingwei Lu
CRChanggeng Ruan
Changgeng Ruan

1 December 2015
Verified
Journal Article
Closed access
LZLi-Li Zhou
Li-Li Zhou
YHyue han
yue han
QZQian Zhu
Qian Zhu
SZShi-Xiang Zhao
Shi-Xiang Zhao
QWQian Wang
Qian Wang
DWDepei Wu
Depei Wu